These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8689815)

  • 1. Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration.
    Wakelkamp M; Alván G; Gabrielsson J; Paintaud G
    Clin Pharmacol Ther; 1996 Jul; 60(1):75-88. PubMed ID: 8689815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.
    Hammarlund MM; Odlind B; Paalzow LK
    J Pharmacol Exp Ther; 1985 May; 233(2):447-53. PubMed ID: 3999028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Input rate as a major determinant of furosemide pharmacodynamics: influence of fluid replacement and hypoalbuminemia.
    Castañeda-Hernández G; Vergés J; Pichette V; Héroux L; Caillé G; du Souich P
    Drug Metab Dispos; 2000 Mar; 28(3):323-8. PubMed ID: 10681377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.
    Klausner EA; Lavy E; Stepensky D; Cserepes E; Barta M; Friedman M; Hoffman A
    J Clin Pharmacol; 2003 Jul; 43(7):711-20. PubMed ID: 12856384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The time of maximum effect for model selection in pharmacokinetic-pharmacodynamic analysis applied to frusemide.
    Wakelkamp M; Alván G; Paintaud G
    Br J Clin Pharmacol; 1998 Jan; 45(1):63-70. PubMed ID: 9489596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
    Sjöström P
    Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide AVP antagonist, and furosemide or hydrochlorothiazide.
    Shoaf SE; Bramer SL; Bricmont P; Zimmer CA
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):213-22. PubMed ID: 17703139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration.
    Bagli M; Süverkrüp R; Quadflieg R; Höflich G; Kasper S; Möller HJ; Langer M; Barlage U; Rao ML
    J Pharmacol Exp Ther; 1999 Nov; 291(2):547-54. PubMed ID: 10525070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.
    Verma AK; da Silva JH; Kuhl DR
    Ann Pharmacother; 2004 Apr; 38(4):544-9. PubMed ID: 14982985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
    Franson KL; Kuk JM; Lam NP; Lau AH
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable furosemide absorption and poor predictability of response in elderly patients.
    Murray MD; Haag KM; Black PK; Hall SD; Brater DC
    Pharmacotherapy; 1997; 17(1):98-106. PubMed ID: 9017769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
    Briukhanov VM; Zverev IaF; Lampatov VV; Zharikov AIu
    Eksp Klin Farmakol; 2007; 70(2):33-6. PubMed ID: 17523448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of natriuretic and diuretic effects of single and divided doses of furosemide.
    Stallings SB; Childress KJ; Maynard SM; Sawyer WT
    Am J Hosp Pharm; 1979 Jan; 36(1):68-71. PubMed ID: 758788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.